It got here to the fore when a volunteer who had the coronavirus vaccine he developed final October bought sick and stopped engaged on the coronavirus vaccine quickly. Johnson & Johnsonhas utilized for a allow in the USA for the coronavirus vaccine it has developed. The corporate acknowledged that it’ll apply for permission in Europe as quickly as potential.
Paul Stoffels, Govt Vice President of Johnson & Johnson, made an announcement on the topic. US Meals and Drug Administration (FDA) He acknowledged that they will begin deliveries instantly after giving permission. Nonetheless, since the advisory fee fashioned by the FDA for vaccines will meet on February 26, it isn’t potential to concern a “advice” resolution for the vaccine earlier than this date.
Johnson & Johnson, in an announcement made about 1 week in the past, has developed a vaccine worldwide. It’s 66 p.c efficient. had expressed. The largest distinction of the vaccine developed by Johnson & Johnson from its rivals is that it doesn’t have to be saved at low temperatures. This makes the transport and preservation of the vaccine a lot simpler.
In line with the data conveyed, Johnson & Johnson, in whole this yr 1 billion doses of vaccine plans to ship. It’s acknowledged that the vaccine might be produced in the USA, Europe, South Africa and India. In the USA, 100 million doses of vaccine are already in change with the firm. 1 billion {dollars} has made a deal. As well as, the USA has 200 million doses of extra vaccine choices. The European Union has signed an settlement with the firm for 400 million doses.
Dikkat: Sitemiz herkese açık bir platform olduğundan, çox fazla kişi paylaşım yapmaktadır. Sitenizden izinsiz paylaşım yapılması durumunda iletişim bölümünden bildirmeniz yeterlidir.
Kaynak: https://www.webtekno.com/johnson-johnson-koronavirus-asisi-icin-izin-basvurusu-h105921.html
